Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:primary amino compound
go back to main search page
Accession:CHEBI:50994 term browser browse the term
Definition:A compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.
Synonyms:related_synonym: primary amino compounds
 cyclic_relationship: is_conjugate_base_of CHEBI:65296


show annotations for term's descendants           Sort by:
alachlor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C49 cytochrome P450 2C49 decreases response to substance EXP CYP2C49 protein results in decreased susceptibility to alachlor CTD PMID:16315095 NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455 		JBrowse link
cysteamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G FMO1 flavin containing dimethylaniline monoxygenase 1 increases metabolic processing EXP FMO1 protein results in increased metabolism of Cysteamine CTD PMID:6439199 NCBI chr 9:63,860,957...63,895,086
Ensembl chr 9:63,868,064...63,895,076 		JBrowse link
fumonisin B1 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGER advanced glycosylation end-product specific receptor increases expression EXP fumonisin B1 results in increased expression of AGER mRNA CTD PMID:32198028 NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162 		JBrowse link
G APAF1 apoptotic peptidase activating factor 1 multiple interactions
increases expression		 EXP fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 protein]
fumonisin B1 results in increased expression of APAF1 mRNA; fumonisin B1 results in increased expression of APAF1 protein		 CTD PMID:36397609 NCBI chr 5:85,166,616...85,258,751
Ensembl chr 5:85,166,628...85,258,364 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions
increases expression		 EXP [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX protein]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of BAX mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX mRNA]
fumonisin B1 results in increased expression of BAX mRNA; fumonisin B1 results in increased expression of BAX protein		 CTD PMID:33905761 PMID:36397609 NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140 		JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression
multiple interactions		 EXP fumonisin B1 results in decreased expression of BCL2 mRNA; fumonisin B1 results in decreased expression of BCL2 protein
[Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with fumonisin B1] results in increased expression of BCL2 protein; [Acetylcysteine co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of BCL2 protein; [fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein; [fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein; [fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]; fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; fumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein]; fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in decreased expression of BCL2 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in decreased expression of BCL2 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in decreased expression of BCL2 mRNA]; Zearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]]; Zearalenone inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]		 CTD PMID:29109043 PMID:33905761 PMID:36397609 NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879 		JBrowse link
G CASP1 caspase 1, apoptosis-related cysteine peptidase multiple interactions EXP N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP1 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP1 protein] CTD PMID:36309173 NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328 		JBrowse link
G CASP10 caspase 10 multiple interactions
increases expression		 EXP 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP10 mRNA] CTD PMID:32198028 NCBI chr15:104,858,082...104,895,941
Ensembl chr15:104,858,100...104,894,933 		JBrowse link
G CASP3 caspase 3 multiple interactions
increases expression		 EXP 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP3 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP3 protein]; [fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form; [fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]; [fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA; [fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] promotes the reaction [deoxynivalenol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]]; deoxynivalenol promotes the reaction [[fumonisin B1 co-treated with Zearalenone] results in increased expression of CASP3 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CASP3 mRNA]]; fumonisin B1 promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 protein modified form]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 protein]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 protein modified form]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP3 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP3 protein]; Zearalenone promotes the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of CASP3 mRNA]
fumonisin B1 results in increased expression of CASP3 mRNA; fumonisin B1 results in increased expression of CASP3 protein; fumonisin B1 results in increased expression of CASP3 protein modified form		 CTD PMID:29109043 PMID:32198028 PMID:33905761 PMID:36397609 NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213 		JBrowse link
G CASP8 caspase 8 multiple interactions
increases expression		 EXP 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of CASP8 mRNA] CTD PMID:32198028 NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468 		JBrowse link
G CASP9 caspase 9 multiple interactions
increases expression		 EXP [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein; [fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 protein modified form]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 protein]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 protein modified form]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of CASP9 protein]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 mRNA]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein modified form]; pyrazolanthrone inhibits the reaction [[fumonisin B1 co-treated with ochratoxin A] results in increased expression of CASP9 protein]
fumonisin B1 results in increased expression of CASP9 mRNA; fumonisin B1 results in increased expression of CASP9 protein; fumonisin B1 results in increased expression of CASP9 protein modified form		 CTD PMID:33905761 PMID:36397609 NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007 		JBrowse link
G CCL2 chemokine (C-C motif) ligand 2 multiple interactions
increases expression
decreases expression		 EXP [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]
fumonisin B1 metabolite results in increased expression of CCL2 mRNA; fumonisin B1 results in increased expression of CCL2 mRNA
fumonisin B1 results in decreased expression of CCL2 mRNA		 CTD PMID:23688591 PMID:30708112 NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026 		JBrowse link
G CCL20 C-C motif chemokine ligand 20 increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of CCL20 mRNA
fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CCL20 mRNA]		 CTD PMID:30708112 NCBI chr15:129,172,743...129,176,069 JBrowse link
G CHUK component of inhibitor of nuclear factor kappa B kinase complex increases expression EXP fumonisin B1 results in increased expression of CHUK mRNA CTD PMID:32198028 NCBI chr14:111,316,178...111,351,669
Ensembl chr14:111,315,141...111,351,868 		JBrowse link
G CLDN1 claudin 1 decreases expression EXP fumonisin B1 results in decreased expression of CLDN1 mRNA; fumonisin B1 results in decreased expression of CLDN1 protein CTD PMID:31557363 NCBI chr13:127,714,857...127,730,628
Ensembl chr13:127,712,777...127,730,657 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 multiple interactions
increases expression		 EXP [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CXCL8 mRNA; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA]; fumonisin B1 promotes the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of CXCL8 mRNA]
fumonisin B1 results in increased expression of CXCL8 mRNA		 CTD PMID:23688591 PMID:30708112 NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861 		JBrowse link
G CYCS cytochrome c, somatic multiple interactions EXP [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA; Acetylcysteine inhibits the reaction [deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA]]; deoxynivalenol promotes the reaction [[Zearalenone co-treated with fumonisin B1] results in increased expression of CYCS mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol promotes the reaction [Zearalenone results in increased expression of CYCS mRNA]]; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of CYCS mRNA] CTD PMID:29109043 PMID:36397609 NCBI chr18:47,169,921...47,172,212
Ensembl chr18:47,169,866...47,173,866 		JBrowse link
G GSDMD gasdermin D multiple interactions EXP belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of GSDMD protein] CTD PMID:36309173 NCBI chr 4:995,753...1,001,964
Ensembl chr 4:995,763...1,000,271 		JBrowse link
G GSR glutathione-disulfide reductase multiple interactions EXP Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]]; fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]; fumonisin B1 promotes the reaction [Zearalenone promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]]; Zearalenone promotes the reaction [fumonisin B1 promotes the reaction [deoxynivalenol results in decreased activity of GSR protein]] CTD PMID:29109043 NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,984 		JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 multiple interactions EXP [fumonisin B1 co-treated with ochratoxin A] results in increased expression of HAVCR1 mRNA CTD PMID:33905761 NCBI chr16:66,162,318...66,208,868 JBrowse link
G IFNG interferon gamma decreases expression EXP fumonisin B1 metabolite results in decreased expression of IFNG protein CTD PMID:30708112 NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670 		JBrowse link
G IL17A interleukin 17A multiple interactions EXP fumonisin B1 inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein]; fumonisin B1 metabolite inhibits the reaction [[deoxynivalenol co-treated with Lipopolysaccharides] results in increased expression of IL17A protein] CTD PMID:30708112 NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153 		JBrowse link
G IL18 interleukin 18 multiple interactions EXP belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL18 protein] CTD PMID:36309173 NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219 		JBrowse link
G IL1A interleukin 1 alpha multiple interactions
decreases expression
increases expression		 EXP [deoxynivalenol co-treated with fumonisin B1] results in decreased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL1A mRNA
fumonisin B1 results in decreased expression of IL1A mRNA
fumonisin B1 results in increased expression of IL1A mRNA		 CTD PMID:23688591 NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119 		JBrowse link
G IL6 interleukin 6 multiple interactions
increases expression
decreases expression		 EXP [deoxynivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [nivalenol co-treated with fumonisin B1] results in decreased expression of IL6 mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL6 mRNA
fumonisin B1 results in increased expression of IL6 mRNA
fumonisin B1 results in decreased expression of IL6 mRNA		 CTD PMID:23688591 PMID:30708112 NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263 		JBrowse link
G LCN2 lipocalin 2 multiple interactions EXP [fumonisin B1 co-treated with ochratoxin A] results in increased expression of LCN2 mRNA CTD PMID:33905761 NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644 		JBrowse link
G LOC110258578 interleukin-1 beta-like increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of IL1B mRNA
[deoxynivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of IL1B mRNA; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B mRNA]; belnacasan inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in increased expression of IL1B protein]		 CTD PMID:23688591 PMID:36309173
G MAP3K14 mitogen-activated protein kinase kinase kinase 14 increases expression EXP fumonisin B1 results in increased expression of MAP3K14 mRNA CTD PMID:32198028 NCBI chr12:18,142,899...18,182,931
Ensembl chr12:18,142,952...18,182,928 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation EXP fumonisin B1 results in increased phosphorylation of MAPK1 protein CTD PMID:31557363 NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513 		JBrowse link
G MAPK10 mitogen-activated protein kinase 10 increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of MAPK10 mRNA
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK10 mRNA]		 CTD PMID:32198028 NCBI chr 8:132,445,818...132,751,575
Ensembl chr 8:132,298,299...132,776,820 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation EXP fumonisin B1 results in increased phosphorylation of MAPK3 protein CTD PMID:31557363 NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567 		JBrowse link
G MAPK8 mitogen-activated protein kinase 8 increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of MAPK8 mRNA; fumonisin B1 results in increased expression of MAPK8 protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK8 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK8 protein]		 CTD PMID:32198028 NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874 		JBrowse link
G MAPK9 mitogen-activated protein kinase 9 increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of MAPK9 mRNA
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of MAPK9 mRNA]		 CTD PMID:32198028 NCBI chr 2:78,338,466...78,399,108
Ensembl chr 2:78,338,376...78,399,100 		JBrowse link
G MUC1 mucin 1, cell surface associated decreases expression EXP fumonisin B1 results in decreased expression of MUC1 mRNA CTD PMID:31557363 NCBI chr 4:94,626,317...94,631,194 JBrowse link
G MUC2 mucin 2, oligomeric mucus/gel-forming increases expression EXP fumonisin B1 results in increased expression of MUC2 mRNA CTD PMID:31557363 NCBI chr 2:689,363...719,542
Ensembl chr 2:689,364...710,330 		JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of NFKB1 mRNA; fumonisin B1 results in increased expression of NFKB1 protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of NFKB1 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fumonisin B1 results in increased expression of NFKB1 protein]		 CTD PMID:32198028 NCBI chr 8:118,391,010...118,478,927
Ensembl chr 8:118,390,638...118,506,691 		JBrowse link
G NTN1 netrin 1 multiple interactions EXP fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of NTN1 mRNA] CTD PMID:33905761 NCBI chr12:54,089,444...54,292,191
Ensembl chr12:54,089,472...54,292,193 		JBrowse link
G OCLN occludin decreases expression EXP fumonisin B1 results in decreased expression of OCLN mRNA; fumonisin B1 results in decreased expression of OCLN protein CTD PMID:31557363 NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,212...47,654,033 		JBrowse link
G SLC15A1 solute carrier family 15 member 1 increases expression EXP fumonisin B1 results in increased expression of SLC15A1 mRNA CTD PMID:33443779 NCBI chr11:67,652,808...67,690,457
Ensembl chr11:67,652,193...67,710,933 		JBrowse link
G SLC1A1 solute carrier family 1 member 1 decreases expression EXP fumonisin B1 results in decreased expression of SLC1A1 mRNA CTD PMID:33443779 NCBI chr 1:217,366,493...217,441,643
Ensembl chr 1:217,366,499...217,441,674 		JBrowse link
G SLC27A4 solute carrier family 27 member 4 decreases expression EXP fumonisin B1 results in decreased expression of SLC27A4 mRNA CTD PMID:33443779 NCBI chr 1:268,773,792...268,788,208
Ensembl chr 1:268,773,806...268,788,731 		JBrowse link
G SLC2A2 solute carrier family 2 member 2 decreases expression EXP fumonisin B1 results in decreased expression of SLC2A2 mRNA CTD PMID:33443779 NCBI chr13:109,592,595...109,614,105
Ensembl chr13:109,587,258...109,638,510 		JBrowse link
G SLC7A1 solute carrier family 7 member 1 decreases expression EXP fumonisin B1 results in decreased expression of SLC7A1 mRNA CTD PMID:33443779 NCBI chr11:6,538,053...6,604,654
Ensembl chr11:6,538,045...6,604,658 		JBrowse link
G SLC7A7 solute carrier family 7 member 7 decreases expression EXP fumonisin B1 results in decreased expression of SLC7A7 mRNA CTD PMID:33443779 NCBI chr 7:76,195,774...76,235,406
Ensembl chr 7:76,198,256...76,235,402 		JBrowse link
G SPP1 secreted phosphoprotein 1 increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of SPP1 mRNA
fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of SPP1 mRNA]; ochratoxin A promotes the reaction [fumonisin B1 results in increased expression of SPP1 mRNA]		 CTD PMID:33905761 NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340 		JBrowse link
G TJP1 tight junction protein 1 decreases expression EXP fumonisin B1 results in decreased expression of TJP1 mRNA; fumonisin B1 results in decreased expression of TJP1 protein CTD PMID:31557363 NCBI chr 1:144,930,387...145,195,857
Ensembl chr 1:144,930,370...145,195,836 		JBrowse link
G TNF tumor necrosis factor multiple interactions
increases expression		 EXP [deoxynivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Lipopolysaccharides co-treated with fumonisin B1] results in increased expression of TNF protein; [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [nivalenol co-treated with fumonisin B1] results in increased expression of TNF mRNA; [nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA; [Zearalenone co-treated with fumonisin B1] results in increased expression of TNF mRNA
fumonisin B1 results in increased expression of TNF mRNA; fumonisin B1 results in increased expression of TNF protein		 CTD PMID:23688591 PMID:30708112 PMID:32198028 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416 		JBrowse link
G TP53 tumor protein p53 increases expression
multiple interactions		 EXP fumonisin B1 results in increased expression of TP53 mRNA
[deoxynivalenol co-treated with fumonisin B1] results in increased expression of TP53 mRNA; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in increased expression of TP53 mRNA]]; Acetylcysteine inhibits the reaction [Zearalenone promotes the reaction [fumonisin B1 results in increased expression of TP53 mRNA]]; fumonisin B1 inhibits the reaction [deoxynivalenol inhibits the reaction [Zearalenone results in increased expression of TP53 mRNA]]; fumonisin B1 promotes the reaction [Zearalenone results in increased expression of TP53 mRNA]; Zearalenone promotes the reaction [[deoxynivalenol co-treated with fumonisin B1] results in increased expression of TP53 mRNA]; Zearalenone promotes the reaction [fumonisin B1 results in increased expression of TP53 mRNA]		 CTD PMID:29109043 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818 		JBrowse link
G TRADD TNFRSF1A associated via death domain increases expression EXP fumonisin B1 results in increased expression of TRADD mRNA CTD PMID:32198028 NCBI chr 6:27,797,594...27,804,654
Ensembl chr 6:27,797,607...27,804,423 		JBrowse link
G TRAF2 TNF receptor associated factor 2 increases expression EXP fumonisin B1 results in increased expression of TRAF2 mRNA CTD PMID:32198028
serotonin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G FOS Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions		 EXP Serotonin results in increased expression of FOS mRNA; Serotonin results in increased expression of FOS protein
sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS protein]		 CTD PMID:11426759 NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression		 EXP sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN protein]
Serotonin results in increased expression of JUN mRNA; Serotonin results in increased expression of JUN protein		 CTD PMID:11426759 NCBI chr 6:153,686,425...153,687,635
Ensembl chr 6:153,685,682...153,687,636 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation
multiple interactions		 EXP Serotonin results in increased phosphorylation of MAPK1 protein
sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK1 protein]		 CTD PMID:11426759 NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation		 EXP sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK3 protein] CTD PMID:11426759 NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 5052
    role 5044
      application 863
        NMR chemical shift reference compound 419
          ammonia 391
            organic amino compound 284
              primary amino compound 52
                (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol 0
                (1S)-2-[(2S,5R)-2-(aminomethyl)-5-prop-1-yn-1-ylpyrrolidin-1-yl]-1-cyclopentyl-2-oxoethanamine 0
                (2-aminoethyl)phosphonic acid + 0
                (2E,5S,6E,8E,10E)-1-aminododeca-2,6,8,10-tetraen-5-ol 0
                (2S,3S,5R,10R,12S,14S,15R,16R)-2-amino-12,16-dimethylicosane-3,5,10,14,15-pentol + 48
                (3-aminopropyl)phosphonic acid 0
                (4-\{4-[2-(gamma-L-glutamylamino)ethyl]phenoxymethyl\}furan-2-yl)methanamine 0
                (R)-(1-aminoethyl)phosphonic acid 0
                (S)-(1-aminoethyl)phosphonic acid + 0
                (Z)-2-methyl-3-aminoperacrylic acid 0
                1,3-thiazol-2-amine 0
                1,5-diamino-1H-imidazole-4-carbonitrile 0
                1-(3-\{5-[4-(aminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl\}phenyl)-3-(2-phenoxyphenyl)urea 0
                1-(4-methoxyphenyl)methanamine 0
                1-(6-chloro-5-fluoroindol-1-yl)-propan-2-amine + 0
                1-amino-1-phenylmethyl phosphonic acid 0
                1-amino-15-oxo-4,7,10-trioxa-14-azaoctadecan-18-oic acid 0
                1-amino-3,3-diethoxypropane 0
                1-phenylpropan-1-amine 0
                2,4-diamino-6,7-diisopropylpteridine 0
                2,4-diaminopteridine-6-carbaldehyde 0
                2,6-diaminotoluene 0
                2-(5-amino-4-cyano-1H-imidazol-1-yl)-5-(4-methylpiperazin-1-yl)benzoic acid 0
                2-(5-amino-4-cyano-1H-imidazol-1-yl)benzoic acid 0
                2-(6-aminohexylamino)-cAMP 0
                2-(7-aminoheptyl)guanidine 0
                2-(aminomethyl)-3,4,6-trichlorophenol + 0
                2-[(1S)-1-aminoethyl]-1-carboxymethyl-5-hydroxy-4-methylimidazole 0
                2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol + 0
                2-amino-2-deoxy-D-galactopyranose + 0
                2-amino-2-deoxy-beta-D-glucopyranosyl beta-D-galactopyranoside 0
                2-amino-2-phenylacetonitrile 0
                2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene 0
                2-amino-4-(3-nitrophenyl)-3-cyano-7-(dimethylamino)-4H-chromene 0
                2-amino-5-chlorophenol 0
                2-amino-cPuMP 0
                2-aminoacetyl fluoride 0
                2-aminoethoxydiphenylborane 0
                2-aminopentanenitrile 0
                2-aminopropan-1-ol + 0
                2-aminopropiophenone + 0
                2-endo-amino-2-exo-benzoyl-3-exo-phenylnorbornane 0
                2-nitro-p-phenylenediamine 0
                3'-N-debenzoyl-2'-deoxytaxol 0
                3'-N-debenzoyltaxol + 0
                3-(2-ethylhexoxy)propan-1-amine 0
                3-[(2-aminoethyl)sulfanyl]-6-ethyl-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 0
                3-[(2-aminoethyl)sulfanyl]-6-methyl-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 0
                3-[(2-aminoethyl)sulfanyl]-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 0
                3-[(2-aminoethyl)thio]-1-azabicyclo[3.2.0]heptan-7-one 0
                3-[(2-aminoethyl)thio]-6-ethyl-1-azabicyclo[3.2.0]heptan-7-one 0
                3-[(2-aminoethyl)thio]-6-methyl-1-azabicyclo[3.2.0]heptan-7-one 0
                3-[(3-aminopropyl)amino]-4-hydroxybenzoic acid 0
                3-[(\{5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl\}sulfanyl)methyl]-N-(2,3-dimethylphenyl)benzamide 0
                3-amino-2,3-dideoxy-scyllo-inosose 0
                3-amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one 0
                3-amino-5-phenylpentane 0
                3-amino-7-(4-methylpiperazin-1-yl)-9-oxo-9H-imidazo[1,2-a]indole-2-carbonitrile 0
                3-amino-9-oxo-9H-imidazo[1,2-a]indole-2-carbonitrile 0
                3-amino-N-[2-(3,4-dihydroxyphenyl)ethyl]propanamide 0
                3-aminopiperidine-2-one 0
                3-aminosuccinimide + 0
                3-methoxytyramine + 0
                3-methoxytyramine sulfate 0
                3-methylthiopropylamine + 0
                3-morpholinopropylamine 0
                3-phenylpropylamine 0
                35-amino-3-methylbacteriohopane-30,31,32,33,34-pentol 0
                35-amino-3-methylbacteriohopane-31,32,33,34-tetrol 0
                35-aminobacteriohopane-30,31,32,33,34-pentol 0
                35-aminobacteriohopane-31,32,33,34-tetrol 0
                4'-oxolividamine 0
                4,5-dihydro-1,3-thiazol-2-amine 0
                4,8-diamino-N-[1-amino-3-(carbamoylamino)-1-oxopropan-2-yl]-2,3,5,7,9-pentahydroxynonanamide + 0
                4-\{[6-endo-amino-6-exo-benzoyl-5-exo-phenylnorbornan-2-yl]oxy\}-4-oxobutanoic acid 0
                4-amino-1,2-oxazolidin-3-one + 0
                4-amino-TEMPO + 0
                4-aminoantipyrine 0
                4-ethoxyaniline + 0
                4-hydroxytryptamine 0
                4-methoxyphenylethylamine + 0
                4-methoxytyramine 0
                4-nitro-1,2-phenylenediamine 0
                4-phenylbutylamine 0
                5-(2-aminoethoxy)methyl-2'-deoxyuridine 0
                5-(2-aminoethyl)-2'-deoxyuridine 0
                5-(N-methyl-N-propyl)amiloride 0
                5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile + 0
                5-amino-1-[3-fluoro-4-(morpholin-4-yl)phenyl]imidazole-4-carbonitrile 0
                5-amino-1-anilinoimidazole-4-carbonitrile 0
                5-amino-1-benzoylimidazole-4-carbonitrile 0
                5-amino-1-formylimidazole-4-carbonitrile 0
                5-amino-4-cyano-1H-imidazole-1-carboxamide 0
                5-amino-5-(4-hydroxybenzyl)-6-(D-ribitylimino)-5,6-dihydrouracil 0
                5-aminofluorescein 0
                5-aminoimidazole ribonucleoside 0
                5-aminosalicylaldehyde 0
                5-hydroxykynurenamine + 0
                5-methoxytryptamine + 0
                5-methyltryptamine 0
                5-nonyloxytryptamine 0
                6'-oxoparomamine 0
                6-aminohexyl phosphate 0
                6-aminonicotinamide 0
                6-hydroxy-pseudooxy-nornicotine 0
                7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid + 0
                7-(methylsulfinyl)heptylamine 0
                7-amino-2-(ethylsulfanyl)-5-oxo-1-phenyl-1,5-dihydro[1,2,4]triazolo[1,5-a]pyridine-6,8-dicarbonitrile 0
                7-aminocholesterol 0
                8-(6-aminohexylamino)-cAMP 0
                8-(6-aminohexylthio)-cAMP 0
                8-(6-aminohexylthio)-cGMP 0
                8-(methylsulfinyl)octylamine 0
                8-(methylthio)octylamine 0
                8-amino-8-demethylriboflavin + 0
                9-aminoacridine 0
                9H-purine-2,6-diamine + 0
                AS1842856 0
                Asn-Ile 0
                CGS 15943 0
                Cys-Ser 0
                D-GlcpN-(1<->1)-D-Galp 0
                E-3810 free base 0
                GSK690693 0
                GlcpN-(1->1)-alpha-D-Galp 0
                IC202A 0
                IC202B 0
                IC202C 0
                Jeffamine M-600 0
                L-779976 0
                L-817818 0
                L-phenylalaninol + 0
                L-tyrosinal + 0
                LDW639 0
                ML240 0
                N(4)-\{2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl\}pentane-1,4-diamine + 0
                N(4)-aminopropylspermidine 0
                N(4)-aminopropylspermine 0
                N(6)-(6-aminohexyl)-cAMP 0
                N(alpha)-acetyl-L-lysine methyl ester 0
                N(tele)-methylhistamine 0
                N,N-didesmethylvenlafaxine 0
                N-(2-aminoethyl)-1-aziridine-ethanamine 0
                N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide 0
                N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide 0
                N-[(2S)-2-aminobutanoyl]glycine 0
                N-[3-(aminomethyl)benzyl]acetamidine 0
                N-acetylcadaverine 0
                N-demethylindolmycin 0
                N-monoacetylalkane-alpha,omega-diamine + 0
                NOC-5 0
                NSC 23766 + 0
                O-phosphoethanolamine + 0
                PM-94128 0
                PQIP 0
                PhIP + 0
                R24 0
                RK-24466 0
                Ro 320-1195 + 0
                S-adenosyl-3-thiopropylamine 0
                SL-327 0
                TMC-52A 0
                TMC-52B 0
                TMC-52C 0
                TMC-52D 0
                TTT-3002 0
                Y-27632 0
                [5-(aminomethyl)-3-furyl]methyl diphosphate 0
                [5-(aminomethyl)-3-furyl]methyl phosphate 0
                acetoprole 0
                aclonifen 0
                agmatine + 0
                alendronic acid 0
                alogliptin 0
                alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                alpha-D-GlcpN-(1->1)-beta-D-Glcp 0
                alpha-D-GlcpN-(1->6)-D-GlcpN 0
                alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpN 0
                alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-D-GlcpN 0
                alpha-allenylagmatine 0
                amfenac + 0
                aminocyclopyrachlor-methyl 0
                aminoethyl nitrate + 0
                amlodipine + 0
                amrubicin + 0
                arterolane 0
                astromicin + 0
                asulam 0
                atenolol-desisopropyl 0
                baclofen 0
                benserazide 0
                beta-D-Galp-(1->3)-D-GlcpN 0
                beta-D-GlcN-(1->6)-D-GlcN + 0
                beta-D-GlcpN-(1->3)-D-GlcpN 0
                beta-aminoarteether + 0
                betazole + 0
                bisucaberin B 0
                butamben + 0
                caldopentamine 0
                cathestatin A 0
                cathestatin B 0
                chloridazon 0
                chrysobactin 0
                crambescidin 800 0
                crambescidin 826 0
                cystamine 0
                cysteamine S-phosphate 0
                deglymidodrine + 0
                desferricoprogen B 0
                dezocine 0
                diamino-poly(ethylene glycol) 0
                didesethylflurazepam 0
                dopamine 3-O-sulfate 0
                dopamine 4-O-sulfate 0
                dopaminoquinone 0
                ent-pavettamine 0
                entinostat + 0
                eribulin 0
                eudistomin C 0
                fenpyrazamine 0
                fingolimod + 0
                fingolimod phosphate 0
                fluciclovine 0
                fluciclovine ((14)C) 0
                fluciclovine ((18)F) 0
                formyl-5-hydroxykynurenamine 0
                fumisoquin A 0
                fumisoquin B 0
                fumonisin B1 48
                fumonisin B2 0
                fumonisin B4 0
                fumonisin B6 0
                fusarithioamide A 0
                gamma-Glu-Tyr 0
                garomefrine 0
                gentamycin 2''-phosphate 0
                halicin 0
                homoserine lactone + 0
                huperzine A 0
                huprine 19 0
                iFSP1 0
                isotabtoxin 0
                kynuramine 0
                linkable Ro 320-1195 analogue 0
                m-tyramine 0
                mediomycin A 0
                mediomycin B 0
                mescaline 0
                methyl 3-(2-phenoxy-6-quinolyl)alaninate 0
                methyl 3-[2-(2,6-dichlorophenyl)quinolin-6-yl]alaninate + 0
                methyl 4-amino-2-(2,3-dihydroxy-3-methylbutyl)benzoate 0
                methyl 4-aminobutanoate 0
                methyl L-cysteinate + 0
                mexiletine + 0
                monodansylcadaverine 0
                muscimol 0
                nepicastat 0
                neutral red base 0
                norbaeocystin 0
                norloline 0
                numidargistat 0
                o-anisidine 0
                omega-aminoaldehyde + 0
                oseltamivir + 0
                oseltamivir acid 0
                oxidopamine 0
                p-anisidine + 0
                pantocin A 0
                paromamine + 0
                pateamine 0
                pavettamine 0
                pibutidine 0
                pirtobrutinib 0
                primary amine + 2
                pyridin-3-ylmethyl \{4-[(2-amino-4-fluorophenyl)carbamoyl]benzyl\}carbamate 0
                pyroglutamine 0
                serotonin + 4
                stealthin C 0
                sulfaphenazole 0
                terazosin + 0
                thiobenzyl benzyloxycarbonyl-L-lysinate 0
                tipifarnib 0
                torin 2 0
                torkinib 0
                tris + 0
                trovafloxacin 0
                tyramine + 0
                tyramine sulfate 0
                wrightiamine A 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 5052
    subatomic particle 5043
      composite particle 5043
        hadron 5071
          baryon 5043
            nucleon 5043
              atomic nucleus 5043
                atom 5043
                  main group element atom 5013
                    main group molecular entity 5012
                      s-block molecular entity 4970
                        hydrogen molecular entity 4964
                          hydrides 4544
                            inorganic hydride 403
                              pnictogen hydride 399
                                nitrogen hydride 399
                                  azane 391
                                    ammonia 391
                                      organic amino compound 284
                                        primary amino compound 52
                                          (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol 0
                                          (1S)-2-[(2S,5R)-2-(aminomethyl)-5-prop-1-yn-1-ylpyrrolidin-1-yl]-1-cyclopentyl-2-oxoethanamine 0
                                          (2-aminoethyl)phosphonic acid + 0
                                          (2E,5S,6E,8E,10E)-1-aminododeca-2,6,8,10-tetraen-5-ol 0
                                          (2S,3S,5R,10R,12S,14S,15R,16R)-2-amino-12,16-dimethylicosane-3,5,10,14,15-pentol + 48
                                          (3-aminopropyl)phosphonic acid 0
                                          (4-\{4-[2-(gamma-L-glutamylamino)ethyl]phenoxymethyl\}furan-2-yl)methanamine 0
                                          (R)-(1-aminoethyl)phosphonic acid 0
                                          (S)-(1-aminoethyl)phosphonic acid + 0
                                          (Z)-2-methyl-3-aminoperacrylic acid 0
                                          1,3-thiazol-2-amine 0
                                          1,5-diamino-1H-imidazole-4-carbonitrile 0
                                          1-(3-\{5-[4-(aminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl\}phenyl)-3-(2-phenoxyphenyl)urea 0
                                          1-(4-methoxyphenyl)methanamine 0
                                          1-(6-chloro-5-fluoroindol-1-yl)-propan-2-amine + 0
                                          1-amino-1-phenylmethyl phosphonic acid 0
                                          1-amino-15-oxo-4,7,10-trioxa-14-azaoctadecan-18-oic acid 0
                                          1-amino-3,3-diethoxypropane 0
                                          1-phenylpropan-1-amine 0
                                          2,4-diamino-6,7-diisopropylpteridine 0
                                          2,4-diaminopteridine-6-carbaldehyde 0
                                          2,6-diaminotoluene 0
                                          2-(5-amino-4-cyano-1H-imidazol-1-yl)-5-(4-methylpiperazin-1-yl)benzoic acid 0
                                          2-(5-amino-4-cyano-1H-imidazol-1-yl)benzoic acid 0
                                          2-(6-aminohexylamino)-cAMP 0
                                          2-(7-aminoheptyl)guanidine 0
                                          2-(aminomethyl)-3,4,6-trichlorophenol + 0
                                          2-[(1S)-1-aminoethyl]-1-carboxymethyl-5-hydroxy-4-methylimidazole 0
                                          2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol + 0
                                          2-amino-2-deoxy-D-galactopyranose + 0
                                          2-amino-2-deoxy-beta-D-glucopyranosyl beta-D-galactopyranoside 0
                                          2-amino-2-phenylacetonitrile 0
                                          2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene 0
                                          2-amino-4-(3-nitrophenyl)-3-cyano-7-(dimethylamino)-4H-chromene 0
                                          2-amino-5-chlorophenol 0
                                          2-amino-cPuMP 0
                                          2-aminoacetyl fluoride 0
                                          2-aminoethoxydiphenylborane 0
                                          2-aminopentanenitrile 0
                                          2-aminopropan-1-ol + 0
                                          2-aminopropiophenone + 0
                                          2-endo-amino-2-exo-benzoyl-3-exo-phenylnorbornane 0
                                          2-nitro-p-phenylenediamine 0
                                          3'-N-debenzoyl-2'-deoxytaxol 0
                                          3'-N-debenzoyltaxol + 0
                                          3-(2-ethylhexoxy)propan-1-amine 0
                                          3-[(2-aminoethyl)sulfanyl]-6-ethyl-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 0
                                          3-[(2-aminoethyl)sulfanyl]-6-methyl-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 0
                                          3-[(2-aminoethyl)sulfanyl]-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 0
                                          3-[(2-aminoethyl)thio]-1-azabicyclo[3.2.0]heptan-7-one 0
                                          3-[(2-aminoethyl)thio]-6-ethyl-1-azabicyclo[3.2.0]heptan-7-one 0
                                          3-[(2-aminoethyl)thio]-6-methyl-1-azabicyclo[3.2.0]heptan-7-one 0
                                          3-[(3-aminopropyl)amino]-4-hydroxybenzoic acid 0
                                          3-[(\{5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl\}sulfanyl)methyl]-N-(2,3-dimethylphenyl)benzamide 0
                                          3-amino-2,3-dideoxy-scyllo-inosose 0
                                          3-amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one 0
                                          3-amino-5-phenylpentane 0
                                          3-amino-7-(4-methylpiperazin-1-yl)-9-oxo-9H-imidazo[1,2-a]indole-2-carbonitrile 0
                                          3-amino-9-oxo-9H-imidazo[1,2-a]indole-2-carbonitrile 0
                                          3-amino-N-[2-(3,4-dihydroxyphenyl)ethyl]propanamide 0
                                          3-aminopiperidine-2-one 0
                                          3-aminosuccinimide + 0
                                          3-methoxytyramine + 0
                                          3-methoxytyramine sulfate 0
                                          3-methylthiopropylamine + 0
                                          3-morpholinopropylamine 0
                                          3-phenylpropylamine 0
                                          35-amino-3-methylbacteriohopane-30,31,32,33,34-pentol 0
                                          35-amino-3-methylbacteriohopane-31,32,33,34-tetrol 0
                                          35-aminobacteriohopane-30,31,32,33,34-pentol 0
                                          35-aminobacteriohopane-31,32,33,34-tetrol 0
                                          4'-oxolividamine 0
                                          4,5-dihydro-1,3-thiazol-2-amine 0
                                          4,8-diamino-N-[1-amino-3-(carbamoylamino)-1-oxopropan-2-yl]-2,3,5,7,9-pentahydroxynonanamide + 0
                                          4-\{[6-endo-amino-6-exo-benzoyl-5-exo-phenylnorbornan-2-yl]oxy\}-4-oxobutanoic acid 0
                                          4-amino-1,2-oxazolidin-3-one + 0
                                          4-amino-TEMPO + 0
                                          4-aminoantipyrine 0
                                          4-ethoxyaniline + 0
                                          4-hydroxytryptamine 0
                                          4-methoxyphenylethylamine + 0
                                          4-methoxytyramine 0
                                          4-nitro-1,2-phenylenediamine 0
                                          4-phenylbutylamine 0
                                          5-(2-aminoethoxy)methyl-2'-deoxyuridine 0
                                          5-(2-aminoethyl)-2'-deoxyuridine 0
                                          5-(N-methyl-N-propyl)amiloride 0
                                          5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile + 0
                                          5-amino-1-[3-fluoro-4-(morpholin-4-yl)phenyl]imidazole-4-carbonitrile 0
                                          5-amino-1-anilinoimidazole-4-carbonitrile 0
                                          5-amino-1-benzoylimidazole-4-carbonitrile 0
                                          5-amino-1-formylimidazole-4-carbonitrile 0
                                          5-amino-4-cyano-1H-imidazole-1-carboxamide 0
                                          5-amino-5-(4-hydroxybenzyl)-6-(D-ribitylimino)-5,6-dihydrouracil 0
                                          5-aminofluorescein 0
                                          5-aminoimidazole ribonucleoside 0
                                          5-aminosalicylaldehyde 0
                                          5-hydroxykynurenamine + 0
                                          5-methoxytryptamine + 0
                                          5-methyltryptamine 0
                                          5-nonyloxytryptamine 0
                                          6'-oxoparomamine 0
                                          6-aminohexyl phosphate 0
                                          6-aminonicotinamide 0
                                          6-hydroxy-pseudooxy-nornicotine 0
                                          7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid + 0
                                          7-(methylsulfinyl)heptylamine 0
                                          7-amino-2-(ethylsulfanyl)-5-oxo-1-phenyl-1,5-dihydro[1,2,4]triazolo[1,5-a]pyridine-6,8-dicarbonitrile 0
                                          7-aminocholesterol 0
                                          8-(6-aminohexylamino)-cAMP 0
                                          8-(6-aminohexylthio)-cAMP 0
                                          8-(6-aminohexylthio)-cGMP 0
                                          8-(methylsulfinyl)octylamine 0
                                          8-(methylthio)octylamine 0
                                          8-amino-8-demethylriboflavin + 0
                                          9-aminoacridine 0
                                          9H-purine-2,6-diamine + 0
                                          AS1842856 0
                                          Asn-Ile 0
                                          CGS 15943 0
                                          Cys-Ser 0
                                          D-GlcpN-(1<->1)-D-Galp 0
                                          E-3810 free base 0
                                          GSK690693 0
                                          GlcpN-(1->1)-alpha-D-Galp 0
                                          IC202A 0
                                          IC202B 0
                                          IC202C 0
                                          Jeffamine M-600 0
                                          L-779976 0
                                          L-817818 0
                                          L-phenylalaninol + 0
                                          L-tyrosinal + 0
                                          LDW639 0
                                          ML240 0
                                          N(4)-\{2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl\}pentane-1,4-diamine + 0
                                          N(4)-aminopropylspermidine 0
                                          N(4)-aminopropylspermine 0
                                          N(6)-(6-aminohexyl)-cAMP 0
                                          N(alpha)-acetyl-L-lysine methyl ester 0
                                          N(tele)-methylhistamine 0
                                          N,N-didesmethylvenlafaxine 0
                                          N-(2-aminoethyl)-1-aziridine-ethanamine 0
                                          N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide 0
                                          N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide 0
                                          N-[(2S)-2-aminobutanoyl]glycine 0
                                          N-[3-(aminomethyl)benzyl]acetamidine 0
                                          N-acetylcadaverine 0
                                          N-demethylindolmycin 0
                                          N-monoacetylalkane-alpha,omega-diamine + 0
                                          NOC-5 0
                                          NSC 23766 + 0
                                          O-phosphoethanolamine + 0
                                          PM-94128 0
                                          PQIP 0
                                          PhIP + 0
                                          R24 0
                                          RK-24466 0
                                          Ro 320-1195 + 0
                                          S-adenosyl-3-thiopropylamine 0
                                          SL-327 0
                                          TMC-52A 0
                                          TMC-52B 0
                                          TMC-52C 0
                                          TMC-52D 0
                                          TTT-3002 0
                                          Y-27632 0
                                          [5-(aminomethyl)-3-furyl]methyl diphosphate 0
                                          [5-(aminomethyl)-3-furyl]methyl phosphate 0
                                          acetoprole 0
                                          aclonifen 0
                                          agmatine + 0
                                          alendronic acid 0
                                          alogliptin 0
                                          alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                                          alpha-D-GlcpN-(1->1)-beta-D-Glcp 0
                                          alpha-D-GlcpN-(1->6)-D-GlcpN 0
                                          alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpN 0
                                          alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-D-GlcpN 0
                                          alpha-allenylagmatine 0
                                          amfenac + 0
                                          aminocyclopyrachlor-methyl 0
                                          aminoethyl nitrate + 0
                                          amlodipine + 0
                                          amrubicin + 0
                                          arterolane 0
                                          astromicin + 0
                                          asulam 0
                                          atenolol-desisopropyl 0
                                          baclofen 0
                                          benserazide 0
                                          beta-D-Galp-(1->3)-D-GlcpN 0
                                          beta-D-GlcN-(1->6)-D-GlcN + 0
                                          beta-D-GlcpN-(1->3)-D-GlcpN 0
                                          beta-aminoarteether + 0
                                          betazole + 0
                                          bisucaberin B 0
                                          butamben + 0
                                          caldopentamine 0
                                          cathestatin A 0
                                          cathestatin B 0
                                          chloridazon 0
                                          chrysobactin 0
                                          crambescidin 800 0
                                          crambescidin 826 0
                                          cystamine 0
                                          cysteamine S-phosphate 0
                                          deglymidodrine + 0
                                          desferricoprogen B 0
                                          dezocine 0
                                          diamino-poly(ethylene glycol) 0
                                          didesethylflurazepam 0
                                          dopamine 3-O-sulfate 0
                                          dopamine 4-O-sulfate 0
                                          dopaminoquinone 0
                                          ent-pavettamine 0
                                          entinostat + 0
                                          eribulin 0
                                          eudistomin C 0
                                          fenpyrazamine 0
                                          fingolimod + 0
                                          fingolimod phosphate 0
                                          fluciclovine 0
                                          fluciclovine ((14)C) 0
                                          fluciclovine ((18)F) 0
                                          formyl-5-hydroxykynurenamine 0
                                          fumisoquin A 0
                                          fumisoquin B 0
                                          fumonisin B1 48
                                          fumonisin B2 0
                                          fumonisin B4 0
                                          fumonisin B6 0
                                          fusarithioamide A 0
                                          gamma-Glu-Tyr 0
                                          garomefrine 0
                                          gentamycin 2''-phosphate 0
                                          halicin 0
                                          homoserine lactone + 0
                                          huperzine A 0
                                          huprine 19 0
                                          iFSP1 0
                                          isotabtoxin 0
                                          kynuramine 0
                                          linkable Ro 320-1195 analogue 0
                                          m-tyramine 0
                                          mediomycin A 0
                                          mediomycin B 0
                                          mescaline 0
                                          methyl 3-(2-phenoxy-6-quinolyl)alaninate 0
                                          methyl 3-[2-(2,6-dichlorophenyl)quinolin-6-yl]alaninate + 0
                                          methyl 4-amino-2-(2,3-dihydroxy-3-methylbutyl)benzoate 0
                                          methyl 4-aminobutanoate 0
                                          methyl L-cysteinate + 0
                                          mexiletine + 0
                                          monodansylcadaverine 0
                                          muscimol 0
                                          nepicastat 0
                                          neutral red base 0
                                          norbaeocystin 0
                                          norloline 0
                                          numidargistat 0
                                          o-anisidine 0
                                          omega-aminoaldehyde + 0
                                          oseltamivir + 0
                                          oseltamivir acid 0
                                          oxidopamine 0
                                          p-anisidine + 0
                                          pantocin A 0
                                          paromamine + 0
                                          pateamine 0
                                          pavettamine 0
                                          pibutidine 0
                                          pirtobrutinib 0
                                          primary amine + 2
                                          pyridin-3-ylmethyl \{4-[(2-amino-4-fluorophenyl)carbamoyl]benzyl\}carbamate 0
                                          pyroglutamine 0
                                          serotonin + 4
                                          stealthin C 0
                                          sulfaphenazole 0
                                          terazosin + 0
                                          thiobenzyl benzyloxycarbonyl-L-lysinate 0
                                          tipifarnib 0
                                          torin 2 0
                                          torkinib 0
                                          tris + 0
                                          trovafloxacin 0
                                          tyramine + 0
                                          tyramine sulfate 0
                                          wrightiamine A 0
paths to the root